The Endocannabinoid System in Human Gestational Tissues in Labor
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/22/2019 |
Start Date: | January 25, 2019 |
End Date: | May 2019 |
Contact: | Melissa L Kozakiewicz, MD |
Email: | mkozakie@wakehealth.edu |
Phone: | 336-716-6289 |
The purpose of this research study is to determine if the endocannabinoid (a biological
system) plays a role in the labor process.
system) plays a role in the labor process.
This is a pilot study to determine the feasibility of identification and quantification of
various components of the endocannabinoid system in the labored versus non-labored
myometrium, placenta and gestational membranes.
various components of the endocannabinoid system in the labored versus non-labored
myometrium, placenta and gestational membranes.
Inclusion Criteria:
- Pregnant women ages > 18 years old
- Pregnant women 22 weeks, 0 days through 42 weeks, 0 days gestation undergoing cesarean
section
- Singleton gestation
Exclusion Criteria:
- Cannabinoid use during pregnancy
- Illicit drug use during pregnancy
- Nonsteroidal anti-inflammatory drug use within 7 days of cesarean section
- Maternal comorbidities including pre-existing diabetes, pre-existing hypertension,
hypertensive disorders of pregnancy (preeclampsia, eclampsia), epilepsy currently
being treated with antiepileptic medication, intraamniotic infection
- Uterine abnormalities
- Fetal anomalies
- Drug use or dependency
We found this trial at
2
sites
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2011
Principal Investigator: Melissa L Kozakiewicz, MD
Phone: 336-716-6289
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
Principal Investigator: Melissa L Kozakiewicz, MD
Phone: 336-716-6289
Click here to add this to my saved trials